87 related articles for article (PubMed ID: 29280449)
1. Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends.
Ohri N; Moshier E; Ho A; Green S; Rhome R; Mazumdar M; Powell S; Tsai CJ
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):549-559. PubMed ID: 29280449
[TBL] [Abstract][Full Text] [Related]
2. Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis.
Zhang J; Lu CY; Chen CH; Chen HM; Wu SY
Breast; 2020 Dec; 54():70-78. PubMed ID: 32947148
[TBL] [Abstract][Full Text] [Related]
3. Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?
Tan CF; Wang J; Zhong XR; Dai ZL; Xiang ZZ; Zeng YY; Wei XY; Xu NY; Liu L
Breast Cancer Res Treat; 2024 Jul; 206(1):45-56. PubMed ID: 38616207
[TBL] [Abstract][Full Text] [Related]
4. Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.
Frasier LL; Holden S; Holden T; Schumacher JR; Leverson G; Anderson B; Greenberg CC; Neuman HB
JAMA Oncol; 2016 Jan; 2(1):95-101. PubMed ID: 26539936
[TBL] [Abstract][Full Text] [Related]
5. Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database.
Agarwal P; Moshier E; Ru M; Ohri N; Ennis R; Rosenzweig K; Mazumdar M
Cancer Control; 2018; 25(1):1073274818789355. PubMed ID: 30021466
[TBL] [Abstract][Full Text] [Related]
6. Temporal Trends and Factors Associated with Receipt of Post-mastectomy Radiation After Neoadjuvant Chemotherapy in Women with cT3 Breast Cancer.
Manik R; Grady CB; Elmore LC; Fieber JH; Freedman GM; Jankowitz RC; Tchou JC; Zhang JQ; Hubbard RA; Fayanju OM
Ann Surg Oncol; 2023 Oct; 30(11):6506-6515. PubMed ID: 37460741
[TBL] [Abstract][Full Text] [Related]
7. De-escalation of Post-mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes.
Halfteck GG; Polychronopoulou YE; Haque W; Weiser R; Hatch SS; Klimberg VS
Ann Surg Oncol; 2023 Dec; 30(13):8335-8343. PubMed ID: 37679538
[TBL] [Abstract][Full Text] [Related]
8. Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
Kim YJ; Park W; Ha B; Park B; Joo J; Kim TH; Park IH; Lee KS; Lee ES; Shin KH; Kim H; Yu JI; Choi DH; Huh SJ; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
Cancer Res Treat; 2017 Oct; 49(4):927-936. PubMed ID: 28052654
[TBL] [Abstract][Full Text] [Related]
9. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
10. Survival benefits of postoperative radiotherapy in patients with cT
Yang J; Zhao J; Chang H; Yan L; Zhang J; Liu H; Ning P
BMC Womens Health; 2024 Jun; 24(1):324. PubMed ID: 38834997
[TBL] [Abstract][Full Text] [Related]
11. American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics.
Novick K; Chadha M; Daroui P; Freedman G; Gao W; Hunt K; Park C; Rewari A; Suh W; Walker E; Wong J; Harris EE
Int J Radiat Oncol Biol Phys; 2024 Feb; 118(2):458-465. PubMed ID: 37478956
[TBL] [Abstract][Full Text] [Related]
12. A prognostic score model to determine which breast cancer patients with 1-3 positive lymph nodes after modified radical mastectomy should receive radiotherapy.
Chen D; Wang H; Song X; Shi F; Kong L; Yu J
Oncotarget; 2018 Jan; 9(1):385-393. PubMed ID: 29416621
[TBL] [Abstract][Full Text] [Related]
13. The trade-off of post-mastectomy radiotherapy usage for the breast cancer patients aged 70 years or older: a study based on SEER database.
Lin J; Luo S; Zhang J; Song C
BMC Geriatr; 2023 Oct; 23(1):625. PubMed ID: 37803254
[TBL] [Abstract][Full Text] [Related]
14. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
Recht A; Comen EA; Fine RE; Fleming GF; Hardenbergh PH; Ho AY; Hudis CA; Hwang ES; Kirshner JJ; Morrow M; Salerno KE; Sledge GW; Solin LJ; Spears PA; Whelan TJ; Somerfield MR; Edge SB
Ann Surg Oncol; 2017 Jan; 24(1):38-51. PubMed ID: 27646018
[TBL] [Abstract][Full Text] [Related]
15. Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012.
Wapnir IL; Kurian AW; Lichtensztajn DY; Clarke CA; Gomez SL
Ann Surg; 2017 Aug; 266(2):353-360. PubMed ID: 27611617
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Postmastectomy Radiation Therapy Receipt by Age and Association With Outcomes in Women With Breast Cancer.
Fasola CE; Graham E; Sha W; Schepel CR; Trufan SJ; Hecksher A; White RL; Hadzikadic-Gusic L
Clin Breast Cancer; 2024 Feb; ():. PubMed ID: 38492996
[TBL] [Abstract][Full Text] [Related]
17. Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival.
Moran MS; Gonsalves L; Goss DM; Ma S
Breast Cancer Res Treat; 2011 Jul; 128(2):543-51. PubMed ID: 21301957
[TBL] [Abstract][Full Text] [Related]
18. Nomogram-Based Risk Stratification to Identify Patients with T3N0M0 Breast Cancer with Survival Benefit from Postmastectomy Radiotherapy.
Meng X; Wang N; Qin P; Jia Q; Ju Z; Jiang Y
Ann Surg Oncol; 2024 Mar; 31(3):1634-1642. PubMed ID: 38087136
[TBL] [Abstract][Full Text] [Related]
19. Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot?
Ellis RJ; Schlick CJR; Feinglass J; Mulcahy MF; Benson AB; Kircher SM; Yang TD; Odell DD; Bilimoria K; Merkow RP
BMJ Qual Saf; 2020 Feb; 29(2):103-112. PubMed ID: 31366576
[TBL] [Abstract][Full Text] [Related]
20. Having ypN0 may not be enough to abandon the Postmastectomy Radiotherapy (PMRT) in Her-2 positive patients.
Fayda M
Radiother Oncol; 2023 Aug; 185():109722. PubMed ID: 37244359
[No Abstract] [Full Text] [Related]
[Next] [New Search]
